Yousefi M - Search Results

1

Duchenne muscular dystrophy: an updated review of common available therapies.

Salmaninejad A, Valilou SF, Bayat H, Ebadi N, Daraei A, Yousefi M, Nesaei A, Mojarrad M. Salmaninejad A, et al. Among authors: yousefi m. Int J Neurosci. 2018 Sep;128(9):854-864. doi: 10.1080/00207454.2018.1430694. Epub 2018 Feb 5. Int J Neurosci. 2018. PMID: 29351004 Review.

2

Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.

Zekri A, Ghaffari SH, Yousefi M, Ghanizadeh-Vesali S, Mojarrad M, Alimoghaddam K, Ghavamzadeh A. Zekri A, et al. Among authors: yousefi m. Mol Cell Endocrinol. 2013 Sep 5;377(1-2):84-92. doi: 10.1016/j.mce.2013.07.002. Epub 2013 Jul 10. Mol Cell Endocrinol. 2013. PMID: 23851143

3

Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.

Salmaninejad A, Gowhari A, Hosseini S, Aslani S, Yousefi M, Bahrami T, Ebrahimi M, Nesaei A, Zal M. Salmaninejad A, et al. Among authors: yousefi m. J Immunotoxicol. 2017 Dec;14(1):137-151. doi: 10.1080/1547691X.2017.1346008. J Immunotoxicol. 2017. PMID: 28693405 Free article. Review.

4

Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.

Yousefi M, Bahrami T, Salmaninejad A, Nosrati R, Ghaffari P, Ghaffari SH. Yousefi M, et al. Cell Oncol (Dordr). 2017 Oct;40(5):419-441. doi: 10.1007/s13402-017-0345-5. Epub 2017 Sep 18. Cell Oncol (Dordr). 2017. PMID: 28921309 Review.

5

Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.

Yousefi M, Nosrati R, Salmaninejad A, Dehghani S, Shahryari A, Saberi A. Yousefi M, et al. Cell Oncol (Dordr). 2018 Apr;41(2):123-140. doi: 10.1007/s13402-018-0376-6. Epub 2018 Mar 22. Cell Oncol (Dordr). 2018. PMID: 29568985 Review.

6

Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer.

Yousefi M, Ghaffari P, Nosrati R, Dehghani S, Salmaninejad A, Abarghan YJ, Ghaffari SH. Yousefi M, et al. Cell Oncol (Dordr). 2020 Feb;43(1):31-49. doi: 10.1007/s13402-019-00470-y. Epub 2019 Dec 11. Cell Oncol (Dordr). 2020. PMID: 31828552 Review.

7

Common therapeutic advances for Duchenne muscular dystrophy (DMD).

Salmaninejad A, Jafari Abarghan Y, Bozorg Qomi S, Bayat H, Yousefi M, Azhdari S, Talebi S, Mojarrad M. Salmaninejad A, et al. Among authors: yousefi m. Int J Neurosci. 2021 Apr;131(4):370-389. doi: 10.1080/00207454.2020.1740218. Epub 2020 Apr 3. Int J Neurosci. 2021. PMID: 32241218 Review.

8

Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.

Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, Hasanzadeh M, Pasdar A. Yousefi M, et al. Cell Oncol (Dordr). 2020 Aug;43(4):515-538. doi: 10.1007/s13402-020-00513-9. Epub 2020 May 16. Cell Oncol (Dordr). 2020. PMID: 32418122 Review.

9

Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials.

Salmaninejad A, Ilkhani K, Marzban H, Navashenaq JG, Rahimirad S, Radnia F, Yousefi M, Bahmanpour Z, Azhdari S, Sahebkar A. Salmaninejad A, et al. Among authors: yousefi m. Curr Pharm Des. 2021;27(28):3161-3169. doi: 10.2174/1381612827666210426100206. Curr Pharm Des. 2021. PMID: 33902409 Review.

10

MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer.

Mirahmadi Y, Nabavi R, Taheri F, Samadian MM, Ghale-Noie ZN, Farjami M, Samadi-Khouzani A, Yousefi M, Azhdari S, Salmaninejad A, Sahebkar A. Mirahmadi Y, et al. Among authors: yousefi m. J Oncol. 2021 Oct 21;2021:3408937. doi: 10.1155/2021/3408937. eCollection 2021. J Oncol. 2021. PMID: 34721577 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,077 results

Search Page

Filters